Aveo Pharmaceuticals (AVEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2020 | 12-2019 | 09-2019 | 06-2019 | 03-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 23,457 | 29,785 | 57,654 | 40,232 | 23,483 |
| Marketable Securities | 10,163 | 17,960 | N/A | N/A | N/A |
| Receivables | 2,779 | 1,631 | 1,090 | 611 | 2,571 |
| Other current assets | 402 | 589 | 200 | 18 | 42 |
| TOTAL | $37,064 | $50,600 | $59,760 | $41,662 | $26,295 |
| Non-Current Assets | |||||
| PPE Net | 100 | N/A | N/A | N/A | N/A |
| Other Non-Current Assets | 1,383 | 0 | 0 | 0 | 212 |
| TOTAL | $1,483 | $N/A | $N/A | $N/A | $212 |
| Total Assets | $38,547 | $50,600 | $59,760 | $41,662 | $26,507 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,965 | 1,466 | 2,183 | 1,963 | 2,109 |
| Accrued Expenses | 6,576 | 8,016 | 6,904 | 6,263 | 8,484 |
| Other current liabilities | 210 | 93 | 513 | 507 | 636 |
| TOTAL | $22,039 | $21,118 | $20,831 | $18,885 | $18,891 |
| Non-Current Liabilities | |||||
| Long Term Debt | 3,610 | 6,197 | 8,714 | 11,166 | 13,511 |
| Deferred Revenues | 1,974 | 1,974 | 1,974 | 1,974 | 1,974 |
| Other Non-Current Liabilities | 3,831 | 5,887 | 8,413 | 6,439 | 8,649 |
| TOTAL | $9,500 | $14,636 | $20,172 | $21,144 | $26,192 |
| Total Liabilities | $31,539 | $35,754 | $41,003 | $40,029 | $45,083 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 16,081 | 16,081 | 16,074 | 16,074 | 16,074 |
| Common Shares | 161 | 16 | 161 | 161 | 139 |
| Retained earnings | -594,002 | -585,621 | -581,160 | -597,589 | -594,454 |
| Other shareholders' equity | 0 | 0 | 0 | 1 | 1 |
| TOTAL | $7,008 | $14,846 | $18,757 | $1,633 | $-18,576 |
| Total Liabilities And Equity | $38,547 | $50,600 | $59,760 | $41,662 | $26,507 |